Abstract
Helicobacter pylori (HP) infection is the main etiopathogenetic agent responsible for inflammatory and ulcerative changes in gastroduodenal mucosa and the basis for both intestinal and diffuse types of gastric carcinoma. In this latter case, intestinal metaplasia is the intermediary between gastritis and cancer. In this study we describe the proliferative activity of gastric epithelium in the progressive stages of HP infection. The expression of proliferating cell nuclear antigen (PCNA), which has proven to be a reliable method for this evaluation, was used as a marker. The study was performed on endoscopic biopsies of the gastric antrum of 40 patients, who were divided into five groups, eight in each group: normal histology and endoscopy, HP−; histological HP+ gastritis with normal endoscopy; histological HP+ gastritis with endoscopic evidence of chronic erosions; complete and incomplete intestinal metaplasia in a HP+ stomach. PCNA was detected by immunohistochemistry and expressed as labeling index, ie, percentage of positive nuclei either in the whole or upper third of foveolae. Our data show a progressive increase of epithelial proliferation in the successive stages of HP infection ranging from gastritis alone to the development of incomplete intestinal metaplasia, a well-known precancerous condition. The proliferative pattern tended to expand towards the upper foveolar third, which in normal conditions does not represent a site of epithelial renewal. These alterations may be related to the development of neoplastic transformations of gastric epithelium. It is well known that genetic mutations are facilitated in proliferating cells. Therefore, our results indicate that the high epithelial turnover, expressed by PCNA LI, may be an indicator of increased risk of neoplastic changes in long-standing untreated HP+ chronic gastritis.
Similar content being viewed by others
References
MacDonald WC, Trier JS, Everett NB: Cell proliferation and migration in stomach, duodenum and rectum of man. Gastroenterology 46:405–417, 1964
Allen A, Flemstrom G, Garner A, Kivilaakso E: Gastroduodenal mucosal protection. Physiol Rev 73(4):823–857, 1993
Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, Serck-Hansen A: Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 33:711–721, 1980
Paull G, Yardley JH: Pathology ofC. pylori associated gastric and esophageal lesions.In Campylobacter pylori in Gastritis and Peptic Ulcer Disease. MI Blaser (ed). Igaku-Shoin, New York, 1989
Sipponen P: Long-term consequences of gastroduodenal inflammation. Eur J Gastroenterol Hepatol 4(2S):25–29, 1992
Correa P: Is gastric carcinoma an infectious disease? N Engl J Med 325:1170–1171, 1991
Sobala GM, Pignatelli B, Schorah CI, Bartsch II, Sanderson M, Dixon MF, Shires S, King RF, Axon ATR: Levels of nitrite, nitrate,N-nitroso compounds, ascorbic and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 12:193–198, 1991
Ierardi E, Monno RA, Ingrosso M, Panza P, DeLorenzis A, Rissi S, Pisani A, Valenza N, Francavilla A: Identification of a subgroup at high risk for gastric cancer in patients with chronic gastritis andHelicobacter pylori. Ir J Med Sci 161(2):70, 1992
Celis JE, Celis A: Cell cycle dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells. Proc Natl Acad Sci USA Vol. 82:3262–3266, 1985
Kamel OW, LeBrun DP, Davis RE, Gerald JB, Wurnke RA: Growth fraction extination of malignant lymphomas in formalin fixed paraffin embedded tissue using anti-PCNA/cyclin 19A2. Am J Pathol 138:1471–1477, 1991
Sarraf CE, McCornick CSF, Brown GR, Price YE, Hall PA, Lane DP, Alison MR: Proliferating cell nuclear antigen immunolocalization in gastrointestinal epithelia. Digestion 50:85–91, 1991
Yamada K, Yoshitaka K, Sato M, Auhnem DJ: Proliferating cell nuclear antigen in normal, preneoplastic and neoplastic colonic epithelium in the rat. Gastroenterology 103:160–167, 1992
Francavilla A, Ierardi E, Barone M, DeLorenzis A, Coppolecchia P: Evaluation of cell proliferationin vivo andin vitro in the epithelium of gastrointestinal tract: A comparison of different techniques. Proceedings of II United Gastroenterology Week, Barcelona, Spain, July 19–24, 1993, A131
Filipe MI, Mendes R, Lane DP, Morris RW: Assessment of proliferating cell nuclear antigen expression in precursor stages of gastric carcinoma using the PC10 antibody to PCNA. Histopathology 22:349–354, 1993
Sokal RR, Rohlf FJ: Biometry, San Francisco, WH Freeman, 1969, p 247
Lorenz J, Gyenes E, Ruth GH, Borsch G: Endoscopic diagnosis ofHelicobacter pylori gastritis. Gastroenterology 104:A126, 1993
Jass JR: Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol 33(9):801–810, 1980
Jass JR, Filipe MI: A variant of intestinal metaplasia associated with gastric carcinoma: A histochemical study. Histopathology 3:191–199, 1979
Rokkas T, Filipe MI, Sladen GE: Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who followed up. Gut 31:1110–1113, 1991
Morson BC: Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 9:377–385, 1955
Morson BC: Precancerous lesions of upper gastrointestinal tract. JAMA 179:311–315, 1962
Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, Fontham E, Tei-Ying Shi:Helicobacter pylori causes hyperproliferation of the gastric epithelium: Pre- and posteradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 88:1870–1875, 1993
Fraser AG, Sim R, Sankey EA, Dillon AP, Pounder RE: Effect of eradication ofHelicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther 8(2):167–173, 1994
Ames BN, Gold LS: Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 249:970–971, 1990
Fox JG: Gastric disease in ferrets: Effect ofHelicobacter mustelae, nitrosamines and reconstructive gastric surgery. Eur J Gastroenterol Hepatol 6(1S):57–65, 1994
Fraser P, Chilvers C, Beral V, Hill MJ: Nitrate and human cancer: A review of the evidence. Int J Epidemiol 9:3–11, 1980
Correa P, Cuello C, Fajardo LF, Haenszel W, Bolanos O, De Ramirez B: Diet and gastric cancer: Nutrition survey in a high risk area. J Natl Cancer Inst 70:673–678, 1983
Chen VW, Abu-Elyazeed RR, Zavala DE, Ktsanes VK, Haenszel W, Cuello C, Montos G, Correa P: Risk factors of gastric precancerous lesions in a high risk Columbion population: Nitrate and nitrite. I Salt. Nutr Cancer 13:59–65, 1990
Iwanaga T, Han H, Adachi K, Fujita T: A novel mechanism for disposing of effect on epithelial cells in the small intestine of guinea pigs. Gastroenterology 105:1089–1097, 1993
Croitoru K, Riddell RII: Reduce, reuse and recycle: Shedding light on shedding cells. Gastroenterology 105:1243–1250, 1993
Vujanovic NL, Polimeno L, Francavilla A, Chambers WH, Starzl TE, Heberman RB, Whiteside T: Changes of liver-resident natural killer cells during liver regeneration in rats. J Immunol (in press)
Author information
Authors and Affiliations
Additional information
This work was supported by the Consiglio Nazionale delle Ricerche ACRO Program grant 94.01132 PF 39.
Rights and permissions
About this article
Cite this article
Panella, C., Ierardi, E., Polimeno, L. et al. Proliferative activity of gastric epithelium in progressive stages ofHelicobacter pylori infection. Digest Dis Sci 41, 1132–1138 (1996). https://doi.org/10.1007/BF02088228
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02088228